Feedback Regulatory News (FDBK)

Feedback plc

Director/PDMR Shareholding

London, UK, 28 October 2020 - Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, has been informed that Rory Shaw, Non-Executive Chairman of the Company, has today purchased 5,235,446 ordinary shares in the Company ("Ordinary Shares") at an average price of 0.992 pence per Ordinary Share.

Following this purchase, Rory Shaw has a total beneficial interest in 9,818,780 Ordinary Shares, equivalent to approximately 0.92 per cent. of the Company's issued share capital.

Enquiries:

Notes to Editors 

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.

Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them